Abstract
Abstract Autoimmune movement disorders are important to recognize when they aretreatable,and earlytreatmentimprovesoutcomes. Wepresent therecentparadigmsidentifiedinautoimmune encephalopathy including diagnostic guidelines, autoantibody pathogen-esis, and therapeutic considerations. We describe the autoimmune encephalitidesassociatedwithmovementdisorderssuchasN-methyl D -aspartatereceptorencephalitisandbasalgangliaencephalitis,theautoimmunemovementdisorders(nonencephalitic)such as opsoclonus–myoclonus–ataxia syndrome and Sydenham chorea, and move-ment disorders associated with systemic autoimmune disorders. In all these disorders,recurrent therapeutic themes areas follows: early immunetherapy improves outcome,adequate immune therapy should be used to achieve complete remission, and relapseprevention reduces disability. receivedApril 5, 2015accepted after revisionApril 6, 2015Issue Theme Movement Disorders;Guest Editors: Nardo Nardocci, MD,and Giovanna Zorzi, MDCopyright © by Georg Thieme Verlag KG,Stuttgart · New YorkDOI http://dx.doi.org/10.1055/s-0035-1558860.ISSN 1304-2580.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
